Suppr超能文献

乙酰甘油醚磷酸胆碱刺激的人血小板可导致离体兔肺出现肺动脉高压和水肿。血栓素A2的作用。

Acetyl glyceryl ether phosphorylcholine-stimulated human platelets cause pulmonary hypertension and edema in isolated rabbit lungs. Role of thromboxane A2.

作者信息

Heffner J E, Shoemaker S A, Canham E M, Patel M, McMurtry I F, Morris H G, Repine J E

出版信息

J Clin Invest. 1983 Feb;71(2):351-7. doi: 10.1172/jci110776.

Abstract

Macrophages, neutrophils, and platelets may play a role in acute edematous lung injury, such as that seen in the adult respiratory distress syndrome (ARDS), but their potential actions and interactions are unclear. Because stimulated human macrophages and neutrophils can release acetyl glyceryl ether phosphorylcholine (AGEPC), a potent platelet activator, we hypothesized that in ARDS, leukocyte release of AGEPC might stimulate platelets to release thromboxane A2 (TXA2), which then produces pulmonary hypertension and lung edema. In support of this premise, we found that pulmonary hypertension and edema occurred in isolated rabbit lungs perfused with human platelets and AGEPC, but not with platelets or AGEPC alone. Infusion of a vasodilator (nitroglycerin) to maintain base-line pulmonary artery pressures in lungs perfused with platelets and AGEPC prevented the development of lung edema suggesting that platelet and AGEPC-induced edema was hydrostatic in nature. Additional experiments suggested that the increased pressure was a result of TXA2 release from platelets stimulated by AGEPC. Specifically, preincubation of platelets with imidazole, a thromboxane synthetase blocker, prior to infusion with AGEPC significantly diminished pulmonary hypertension and prevented lung edema. Furthermore, pretreating lung preparations with 13-azaprostanoic acid, a TXA2 antagonist, before infusion of AGEPC and untreated platelets also reduced the pulmonary hypertension and blocked the lung edema. The role of TXA2 was further suggested when perfusates from lungs infused with platelets and AGEPC developed high levels of TXA2, whereas perfusates from controls did not. These results suggest that platelet aggregation induced by AGEPC may contribute to ARDS by releasing TXA2, which raises microvascular pressure and increases edema formation, especially when an underlying permeability defect is present.

摘要

巨噬细胞、中性粒细胞和血小板可能在急性肺水肿性肺损伤中发挥作用,如在成人呼吸窘迫综合征(ARDS)中所见,但它们的潜在作用和相互作用尚不清楚。由于受刺激的人巨噬细胞和中性粒细胞可释放强效血小板激活剂乙酰甘油醚磷酸胆碱(AGEPC),我们推测在ARDS中,AGEPC的白细胞释放可能刺激血小板释放血栓素A2(TXA2),进而导致肺动脉高压和肺水肿。支持这一假设的是,我们发现,在灌注人血小板和AGEPC的离体兔肺中出现了肺动脉高压和肺水肿,但单独灌注血小板或AGEPC时则未出现。在灌注血小板和AGEPC的肺中输注血管扩张剂(硝酸甘油)以维持基线肺动脉压可预防肺水肿的发生,这表明血小板和AGEPC诱导的水肿本质上是静水压性的。进一步的实验表明,压力升高是AGEPC刺激血小板释放TXA2的结果。具体而言,在输注AGEPC之前用血栓素合成酶阻滞剂咪唑预孵育血小板可显著减轻肺动脉高压并预防肺水肿。此外,在输注AGEPC和未处理的血小板之前用TXA2拮抗剂13-氮杂前列腺素预处理肺制剂也可降低肺动脉高压并阻止肺水肿。当灌注了血小板和AGEPC的肺的灌注液中TXA2水平升高,而对照的灌注液中则没有时,TXA2的作用得到了进一步提示。这些结果表明,AGEPC诱导的血小板聚集可能通过释放TXA2导致ARDS,TXA2会升高微血管压力并增加水肿形成,尤其是在存在潜在通透性缺陷的情况下。

相似文献

引用本文的文献

2
Platelets in lung biology.肺生物学中的血小板。
Annu Rev Physiol. 2013;75:569-91. doi: 10.1146/annurev-physiol-030212-183752. Epub 2012 Oct 1.
10
Pulmonary leukosequestration induced by hind limb ischemia.
Ann Surg. 1987 Aug;206(2):162-7. doi: 10.1097/00000658-198708000-00008.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验